To date, there havebeen no major impacts to the business and...

To date, there have
been no major impacts to the business and accordingly the 25% pay reduction will be removed from
1 September 2020

But WP, milesotnes have not been reached and the company is still yet to make a profit whilst you CEO pay is double that what is sld be based on peer sized map cap Co's that actually make a profit. If the company misses 3+mil surely the board can go without too?

Under the Agreement, Anteris was to receive up to $A3.73M if gross revenue from LeMaitre
CardioCel® and VascuCel® product sales exceeded $A29.8M in the first 12 months (11 October 2020)
or $A1.8M if gross revenue from product sales exceed $A22.4M in the first 12 months. ($A amounts
calculated at the then $US1/$A0.67 FX rate.)
Anteris still expects the $US0.65M post-closing instalment payment on the first anniversary of the
Agreement this October 2020. A second, equal post-closing instalment is due on the Agreement’s
second anniversary.